Targeting CXCR4-dependent immunosuppressive Ly6C(low) monocytes improves antiangiogenic therapy in colorectal cancer

Antiangiogenic therapy with antibodies against VEGF (bevacizumab) or VEGFR2 (ramucirumab) has been proven efficacious in colorectal cancer (CRC) patients. However, the improvement in overall survival is modest and only in combination with chemotherapy. Thus, there is an urgent need to identify poten...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Proc Natl Acad Sci U S A
Main Authors: Jung, Keehoon, Heishi, Takahiro, Incio, Joao, Huang, Yuhui, Beech, Elizabeth Y., Pinter, Matthias, Ho, William W., Kawaguchi, Kosuke, Rahbari, Nuh N., Chung, Euiheon, Kim, Jun Ki, Clark, Jeffrey W., Willett, Christopher G., Yun, Seok Hyun, Luster, Andrew D., Padera, Timothy P., Jain, Rakesh K., Fukumura, Dai
פורמט: Artigo
שפה:Inglês
יצא לאור: National Academy of Sciences 2017
נושאים:
Biological Sciences
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5625928/
https://ncbi.nlm.nih.gov/pubmed/28900008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1710754114
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים